Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
7.25
-0.42 (-5.54%)
Jun 27, 2025, 4:00 PM - Market closed
Company Description
Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.
Moolec Science SA
| Country | United Kingdom |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 52 |
| CEO | Gaston Paladini |
Contact Details
No contact details available.
Stock Details
| Ticker Symbol | MLEC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001937737 |
| ISIN Number | LU2559000059 |
| SIC Code | 2200 |
Key Executives
| Name | Position |
|---|---|
| Henk Hoogenkamp Ph.D. | Co-Founder and Chief Product Officer |
| Martin Salinas Ph.D. | Chief of Technology and Co-Founder |
| Jose Lopez Lecube M.B.A. | Chief Financial Officer and Executive Director |
| Dr. Amit Dhingra Ph.D. | Chief Science Officer |
| Florencia Bottero | Corporate Counsel and Secretary of the Board |
| Catalina Jones B.A. | Chief of Staff and Sustainability |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2025 | 6-K | Report of foreign issuer |
| Jun 17, 2025 | 6-K | Report of foreign issuer |
| Jun 17, 2025 | POS AM | Post-Effective amendments for registration statement |
| Jun 16, 2025 | 6-K | Report of foreign issuer |
| Jun 16, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Jun 16, 2025 | POS AM | Post-Effective amendments for registration statement |
| Jun 4, 2025 | 6-K | Report of foreign issuer |
| May 13, 2025 | 6-K | Report of foreign issuer |
| Apr 29, 2025 | 6-K | Report of foreign issuer |
| Apr 23, 2025 | 6-K | Report of foreign issuer |